{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:08:12Z","timestamp":1784128092364,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1 CA217798"],"award-info":[{"award-number":["PO1 CA217798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA228524"],"award-info":[{"award-number":["R01 CA228524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA247471"],"award-info":[{"award-number":["R01 CA247471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA254036"],"award-info":[{"award-number":["R01 CA254036"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44 CA235991"],"award-info":[{"award-number":["R44 CA235991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA206444"],"award-info":[{"award-number":["RO1 CA206444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA210637"],"award-info":[{"award-number":["RO1 CA210637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA210240"],"award-info":[{"award-number":["U01 CA210240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.semcancer.2022.03.022","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T17:41:18Z","timestamp":1648316478000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"P2","title":["Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer"],"prefix":"10.1016","volume":"86","author":[{"given":"Koelina","family":"Ganguly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita","family":"Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moorthy P.","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6561","key":"10.1016\/j.semcancer.2022.03.022_bib1","doi-asserted-by":"crossref","first-page":"eabj0486","DOI":"10.1126\/science.abj0486","article-title":"Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis","volume":"373","author":"Del Poggetto","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib2","first-page":"6","article-title":"Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects","volume":"6","author":"Li","year":"2020","journal-title":"Chronic Dis. Transl. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2022.03.022_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030676","article-title":"Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity","volume":"20","author":"Padoan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.semcancer.2022.03.022_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.semcancer.2022.03.022_bib5","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.semcancer.2022.03.022_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10555-020-09896-5","article-title":"Unraveling mucin domains in cancer and metastasis: when protectors become predators","volume":"39","author":"Ganguly","year":"2020","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2022.03.022_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10555-018-09775-0","article-title":"Cancer-associated mucins: role in immune modulation and metastasis","volume":"38","author":"Bhatia","year":"2019","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1089\/jir.2016.0076","article-title":"Mucosal chemokines","volume":"37","author":"Hernandez-Ruiz","year":"2017","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12965","article-title":"Mucosal chemokine CXCL17: What is known and not known","volume":"93","author":"Xiao","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.gastro.2010.10.009","article-title":"CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis","volume":"140","author":"Hiraoka","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.semcancer.2022.03.022_bib12","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.174.9.5490","article-title":"Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo","volume":"174","author":"Shurin","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2022.03.022_bib13","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1096\/fj.06-7646com","article-title":"Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo","volume":"21","author":"Hubert","year":"2007","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.semcancer.2022.03.022_bib14","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.4049\/jimmunol.1102903","article-title":"CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity","volume":"188","author":"Burkhardt","year":"2012","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2022.03.022_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044080","article-title":"CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4\/80- cells and promotes tumor progression","volume":"7","author":"Matsui","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.1401704","article-title":"Cutting edge: GPR35\/CXCR8 is the receptor of the mucosal chemokine CXCL17","volume":"194","author":"Maravillas-Montero","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib17","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1038\/s41467-020-18207-z","article-title":"Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells\u2019 heterogeneity","volume":"11","author":"Schlesinger","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1074-7613(00)80531-2","article-title":"TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development","volume":"7","author":"Vicari","year":"1997","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0","article-title":"The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9","volume":"30","author":"Wurbel","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2022.03.022_bib20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.molonc.2015.04.012","article-title":"CCR9-mediated signaling through beta-catenin and identification of a novel CCR9 antagonist","volume":"9","author":"Lee","year":"2015","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.03.022_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1586\/1744666X.2.5.759","article-title":"Role of CCL25\/CCR9 in immune homeostasis and disease","volume":"2","author":"Svensson","year":"2006","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib22","first-page":"2071","article-title":"The role of chemokine receptor 9\/chemokine ligand 25 signaling: From immune cells to cancer cells","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.semcancer.2022.03.022_bib23","first-page":"3571","article-title":"CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner","volume":"19","author":"Niu","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2022.03.022_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/dna.2015.3104","article-title":"CCL25\/CCR9 signal promotes migration and invasion in hepatocellular and breast cancer cell lines","volume":"35","author":"Zhang","year":"2016","journal-title":"DNA Cell Biol."},{"issue":"12","key":"10.1016\/j.semcancer.2022.03.022_bib25","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1002\/jcp.29782","article-title":"CCR9 and CCL25: a review of their roles in tumor promotion","volume":"235","author":"Xu","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"11","key":"10.1016\/j.semcancer.2022.03.022_bib26","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s11605-009-1002-8","article-title":"CC chemokine receptor 9 enhances proliferation in pancreatic intraepithelial neoplasia and pancreatic cancer cells","volume":"13","author":"Shen","year":"2009","journal-title":"J. Gastrointest. Surg."},{"issue":"4","key":"10.1016\/j.semcancer.2022.03.022_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.15252\/emmm.201404414","article-title":"A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes","volume":"7","author":"Khandelwal","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2022.03.022_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12307-013-0130-6","article-title":"Paracrine activation of chemokine receptor CCR9 enhances the invasiveness of pancreatic cancer cells","volume":"6","author":"Heinrich","year":"2013","journal-title":"Cancer Microenviron."},{"issue":"29","key":"10.1016\/j.semcancer.2022.03.022_bib29","doi-asserted-by":"crossref","first-page":"22313","DOI":"10.1074\/jbc.M001461200","article-title":"Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2)","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"7355","key":"10.1016\/j.semcancer.2022.03.022_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.semcancer.2022.03.022_bib31","doi-asserted-by":"crossref","first-page":"13787","DOI":"10.1073\/pnas.1203339109","article-title":"MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer","volume":"109","author":"Chaika","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.semcancer.2022.03.022_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.semcancer.2022.03.022_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"Ohlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2022.03.022_bib34","article-title":"Interactions Between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines","volume":"13","author":"Gorchs","year":"2021"},{"issue":"12","key":"10.1016\/j.semcancer.2022.03.022_bib35","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00262-017-2052-5","article-title":"Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression","volume":"66","author":"Fu","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2022.03.022_bib36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2022.03.022_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101417","article-title":"Fibroblast heterogeneity in tumor micro-environment: role in immunosuppression and new therapies","volume":"48","author":"Mhaidly","year":"2020","journal-title":"Semin Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouliere","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.semcancer.2022.03.022_bib39","article-title":"NF-kappaB Dependent Chemokine Signaling in Pancreatic Cancer","volume":"11","author":"Geismann","year":"2019"},{"issue":"6","key":"10.1016\/j.semcancer.2022.03.022_bib40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.semcancer.2022.03.022_bib41","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"17","key":"10.1016\/j.semcancer.2022.03.022_bib42","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting CXCL12\/CXCR4 axis in tumor immunotherapy","volume":"26","author":"Zhou","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"50","key":"10.1016\/j.semcancer.2022.03.022_bib43","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188362","article-title":"Odyssey of trefoil factors in cancer: diagnostic and therapeutic implications","volume":"1873","author":"Jahan","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2022.03.022_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094909","article-title":"Trefoil factor family (TFF) peptides and their links to inflammation: a re-evaluation and new medical perspectives","volume":"22","author":"Hoffmann","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.semcancer.2022.03.022_bib46","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1074\/jbc.M804935200","article-title":"Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines","volume":"284","author":"Dubeykovskaya","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.semcancer.2022.03.022_bib47","doi-asserted-by":"crossref","first-page":"18440","DOI":"10.1074\/jbc.M200468200","article-title":"Protein kinase C and ERK activation are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion","volume":"277","author":"Graness","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canlet.2007.10.021","article-title":"CXCL14 expression and potential function in pancreatic cancer","volume":"259","author":"Wente","year":"2008","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.semcancer.2022.03.022_bib49","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0813144106","article-title":"CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth","volume":"106","author":"Augsten","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.semcancer.2022.03.022_bib50","first-page":"2569","article-title":"The glycosylation landscape of pancreatic cancer","volume":"17","author":"Munkley","year":"2019","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.semcancer.2022.03.022_bib51","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2013.07.014","article-title":"Inflammatory cytokines in human pancreatic cancer","volume":"345","author":"Roshani","year":"2014","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.semcancer.2022.03.022_bib53","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00262-005-0047-0","article-title":"Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival","volume":"55","author":"Bellone","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cyto.2015.04.006","article-title":"Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines","volume":"75","author":"Bassaganas","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.semcancer.2022.03.022_bib55","doi-asserted-by":"crossref","DOI":"10.20517\/2394-4722.2018.112","article-title":"Determination of cytokine regulated glycan expression by using molecularly imprinted polymers targeting sialic acid","volume":"2019","author":"Zhang","year":"2019","journal-title":"J. Cancer Metastas-.-. Treat."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BJ20070958","article-title":"IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and\/or sulfated Lewisx epitopes in the human bronchial mucosa","volume":"410","author":"Groux-Degroote","year":"2008","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.semcancer.2022.03.022_bib57","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/onc.2009.467","article-title":"Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors","volume":"29","author":"Mejias-Luque","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.semcancer.2022.03.022_bib58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000453594","article-title":"Transmembrane mucins: signaling receptors at the intersection of inflammation and cancer","volume":"9","author":"van Putten","year":"2017","journal-title":"J. Innate Immun."},{"issue":"39","key":"10.1016\/j.semcancer.2022.03.022_bib59","doi-asserted-by":"crossref","first-page":"24198","DOI":"10.1074\/jbc.272.39.24198","article-title":"Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines","volume":"272","author":"Burdick","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/biom6020026","article-title":"A bitter sweet symphony: immune responses to altered O-glycan epitopes in cancer","volume":"6","author":"Cornelissen","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.semcancer.2022.03.022_bib61","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3389\/fimmu.2018.02807","article-title":"Modulation of immune tolerance via siglec-sialic acid interactions","volume":"9","author":"Lubbers","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2022.03.022_bib62","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fimmu.2019.01047","article-title":"Sugar free: novel immunotherapeutic approaches targeting siglecs and sialic acids to enhance natural killer cell cytotoxicity against cancer","volume":"10","author":"Daly","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2022.03.022_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051260","article-title":"Siglec ligands","volume":"10","author":"Gonzalez-Gil","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.semcancer.2022.03.022_bib64","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.1507706113","article-title":"Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells","volume":"113","author":"Perdicchio","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imr.12526","article-title":"Viewing Siglecs through the lens of tumor immunology","volume":"276","author":"Fraschilla","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2022.03.022_bib66","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2022.03.022_bib67","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ni.3552","article-title":"The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9","volume":"17","author":"Beatson","year":"2016","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.semcancer.2022.03.022_bib68","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1073\/pnas.1813020116","article-title":"The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins","volume":"116","author":"Malaker","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2022.03.022_bib69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1476-4598-9-118","article-title":"Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes","volume":"9","author":"Belisle","year":"2010","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2022.03.022_bib70","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947852","article-title":"Chemokines and galectins form heterodimers to modulate inflammation","volume":"21","author":"Eckardt","year":"2020","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2022.03.022_bib71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/002215540104900414","article-title":"Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer","volume":"49","author":"Berberat","year":"2001","journal-title":"J. Histochem. Cytochem."},{"issue":"7","key":"10.1016\/j.semcancer.2022.03.022_bib72","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1007\/s13277-015-3233-5","article-title":"Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer","volume":"36","author":"Tang","year":"2015","journal-title":"Tumour Biol."},{"issue":"10","key":"10.1016\/j.semcancer.2022.03.022_bib73","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/ijc.26290","article-title":"High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer","volume":"130","author":"Tang","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2022.03.022_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2017.03.024","article-title":"Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis","volume":"397","author":"Qian","year":"2017","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.semcancer.2022.03.022_bib75","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1053\/j.gastro.2017.12.014","article-title":"Galectin-3 mediates tumor cell-stroma interactions by activating pancreatic stellate cells to produce cytokines via integrin signaling","volume":"154","author":"Zhao","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.semcancer.2022.03.022_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tibs.2009.10.003","article-title":"Mucin-interacting proteins: from function to therapeutics","volume":"35","author":"Senapati","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2022.03.022_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1158\/1078-0432.CCR-10-1937","article-title":"Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer","volume":"17","author":"Senapati","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"34","key":"10.1016\/j.semcancer.2022.03.022_bib78","doi-asserted-by":"crossref","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Argueso","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2022.03.022_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9997625","article-title":"IL-17 is a key regulator of mucin-galectin-3 interactions in asthma","volume":"2021","author":"Mammen","year":"2021","journal-title":"Int. J. Cell Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2022.03.022_bib80","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100012","article-title":"Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2","volume":"38","author":"Cherfils-Vicini","year":"2019","journal-title":"EMBO J."},{"issue":"22","key":"10.1016\/j.semcancer.2022.03.022_bib81","article-title":"Mucin 5AC-mediated CD44\/ITGB1 clustering mobilizes adipose-derived mesenchymal stem cells to modulate pancreatic cancer stromal heterogeneity","volume":"S0016-5085","author":"Ganguly","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X22000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X22000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:12:46Z","timestamp":1760919166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X22000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":81,"alternative-id":["S1044579X22000785"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.022","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}